NCT05790824

Brief Summary

The hypothesis is that the use of spa therapy in Saint-Lary Soulan for knee osteoarthritis treatment would have a therapeutic effect on this pathology. The main objective of this external comparison study is to evaluate the comparative effectiveness at 6 months of spa therapy in the Saint-Lary Soulan spa center on functional disability and pain (MCII: Minimal Clinical Important Improvement) in knee osteoarthritis compared to the control group of the Thermarthrose multicenter randomized clinical trial, receiving standard cares. The patients included in the Larytherm cohort will undergo a three-week spa therapy in Saint-Lary Soulan with a follow-up of 6 months after the end of spa therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable knee-osteoarthritis

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 24, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 30, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

May 1, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2024

Completed
Last Updated

August 20, 2024

Status Verified

August 1, 2024

Enrollment Period

9 months

First QC Date

February 24, 2023

Last Update Submit

August 19, 2024

Conditions

Keywords

painspa therapyfunctional disability

Outcome Measures

Primary Outcomes (1)

  • Number of patients with Minimal Clinically Important Improvement (MCII)

    Improvement from baseline of at least 9.1 points on the Western Ontario and McMaster University osteoarthritis (WOMAC) index standardized functional subscale of 0-100 and/or at least 1.99 cm on the Visual Analogue Scale (VAS) for pain without knee surgery, at 6 months. WOMAC index (functional subscale): functional assessment index for knee osteoarthritis, exploring the daily function. The scoring system used for the answers to the questions is the Lickert scale with 5 possible answers (none = 0; minimal = 1; moderate = 2; severe = 3; extreme = 4). Visual Analogue Scale for the evaluation of knee osteoarthritis-related pain for the index knee experienced over the last eight days. The scale is presented as a 10 cm horizontal line, the left end (= 0 cm) corresponding to no pain and the right end (= 10 cm) to the maximum imaginable pain. This outcome will be evaluated in the Larytherm cohort and compared to the control group of the Thermarthrose study.

    6 months after the end of spa therapy

Secondary Outcomes (12)

  • Relative change from baseline in the WOMAC functional subscale index at the end of the spa therapy and at 6 months after the end of the spa therapy.

    Baseline, end of spa therapy (week 3) and 6 months after the end of spa therapy

  • Relative change from baseline in the WOMAC index (full questionnaire) at the end of the spa therapy and at 6 months after the end of the spa therapy.

    Baseline, end of spa therapy (week 3) and 6 months after the end of spa therapy

  • Relative change from baseline in the knee osteoarthritis pain measured by the Visual Analogue Scale (VAS) for pain at the end of the spa therapy and at 6 months after the end of the spa therapy.

    Baseline, end of spa therapy (week 3) and 6 months after the end of the spa therapy

  • Relative change from baseline in fatigue measured by the Visual Analogue Scale (VAS) for fatigue at the end of the spa therapy and at 6 months after the end of the spa therapy.

    Baseline, end of spa therapy (week 3) and 6 months after the end of spa therapy

  • Relative change from baseline in Lequesne's algo-functional index at the end of the spa therapy and at 6 months after the end of the spa therapy.

    Baseline, end of spa therapy (week 3) and 6 months after the end of spa therapy

  • +7 more secondary outcomes

Study Arms (1)

Spa therapy

EXPERIMENTAL

Protocol of spa therapy in rheumatology for 3 weeks

Other: Spa therapy

Interventions

The "RH2" rheumatology treatment protocol will propose treatments that can be carried out with water from the SL5 borehole and will be composed of: * 54 treatments among the following treatments: * Swimming pool, 15 minutes (code 201) * Bath with aerobath, 10 minutes (code 205) * Bath with immersion shower, 10 minutes (code 206) * Cataplasm in multiple local application, 10 minutes (code 408) * 18 sessions of mobilization pool, 15 minutes (code 601)

Spa therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • painful knee due to knee osteoarthritis diagnosed for more than 6 months (confirmed by the general practitioner responsible for the identification of the patient) with at least three of the six clinical criteria defined by the American College of Rheumatology:
  • age \> 50 years
  • morning stiffness lasting \< 30 minutes
  • articular crepitation when moving the knee
  • globular knee with bony hypertrophy on physical examination
  • periarticular bone pain on physical examination
  • absence of local heat on palpation
  • Visual Analogue Scale for the evaluation of pain felt over the last eight days with a score greater than or equal to 3/10
  • affiliated or benefiting from a Social Security plan
  • agreeing to participate in the study, having completed and signed the Patient's Free and Informed Consent Form

You may not qualify if:

  • knee osteoarthritis limited to the patello-femoral joint
  • at least one of the following diseases/conditions:
  • Contra-indications for the realization of spa therapy: evolving cancer, dementia, severe dermatosis, infectious state not stabilized, pregnancy, severe cardiac and respiratory insufficiency, phlebitis, inflammatory rheumatism, psychosis, acute spinal pain
  • Acute arthritis of septic or inflammatory origin
  • an index knee arthroplasty within the last 6 months or a planned arthroplasty on the index knee within the next 6 months
  • corticosteroids infiltration or viscosupplementation within the last 3 months
  • spa therapy within the previous 6 months
  • link with the staff of the Saint-Lary Soulan spa center or the physicians participating in the study (family, employee, etc.)
  • language barrier (unable to read the information letter, complete the patient agreement form or self-questionnaires)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre thermal de Saint-Lary Soulan

Saint-Lary-Soulan, 65170, France

Location

Related Publications (1)

  • Forestier R, Desfour H, Tessier JM, Francon A, Foote AM, Genty C, Rolland C, Roques CF, Bosson JL. Spa therapy in the treatment of knee osteoarthritis: a large randomised multicentre trial. Ann Rheum Dis. 2010 Apr;69(4):660-5. doi: 10.1136/ard.2009.113209. Epub 2009 Sep 3.

MeSH Terms

Conditions

Osteoarthritis, KneePain

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Patrick Blin

    Bordeaux PharmacoEpi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: External comparison study between Larytherm cohort patients and Thermarthrose control patients
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 24, 2023

First Posted

March 30, 2023

Study Start

May 1, 2023

Primary Completion

January 12, 2024

Study Completion

January 12, 2024

Last Updated

August 20, 2024

Record last verified: 2024-08

Locations